Neuro Bank Flashcards

1
Q

Acute migraine treatment - 1st line

A

oral triptan + NSAID/paracetamol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Acute migraine treatment: aged 12-17

A

nasal triptan + NSAID/paracetamol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Acute migraine treatment - 2nd line

A

metoclopramide or prochlorperazine

+/- non-oral NSAID/triptan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Migraine prophylaxis - 1st line

A

topiramate or propranolo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Migraine prophylaxis - 2nd line

A

10 sessions of acupuncture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Migraine prophylaxis - menstrual migraine

A

frovatriptan or zolmitriptan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Classical features of vestibular schwannoma

A

-vertigo
-sensorineural hearing loss
-tinnitus
-absent corneal reflex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Parkinsons treatment: first line - motor symptoms affecting QOL

A

Levodopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Parkinsons treatment: first line - motor symptoms not affecting QOL

A

Dopamine agonist (ropinirole, bromocriptine, cabergoline)
/
Levodopa
/
MAO-B inhibitor (selegiline)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Parkinsons treatment: 2nd line

A

Levodopa plus adjunct:
-dopamine agonist
-MAO-B inhibitor
-COMT inhibitor (entacapone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Common features of MND

A

-fasciculations
-no sensory signs
-LMN + UMN signs
-wasting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Peripheral neuropathy - causes of predominantly motor

A

GBS
lead poisining
HSMN - CMT
CIDP
diptheria
porphyria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Peripheral neuropathy - causes of predominantly sensory

A

diabetes
leprosy
B12 deficiency
amyloidosis
uraemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Features of bell’s palsy

A

LMN facial nerve palsy - forehead affected

Sometimes: post-auricular pain, altered taste, dry eyes, hyperacusis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Management of Bell’s palsy

A

Prednisolone 1mg/kg 10 days

Within 72 hours of onset

Eye care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Guillain-Barre - classic features

A

Progressive weakness of all four limbs
-LL > UL
-Proximal > distal
-Minimal sensory
-areflexia
-cranial nerves - diplopa
- autonomic - retention

17
Q

Neuropathic pain - 1st line

A

amitriptyline, duloxetine, gabapentin or pregabalin

18
Q

Neuropathic pain - 2nd line

A

Try one of the other of: amitriptyline, duloxetine, gabapentin or pregabalin

19
Q

Neuropathic pain - 3rd line

A

Tramadol rescue therapy

20
Q

Neuropathic pain - topical

A

Capsaicin

21
Q

MS treatment - acute relapse

A

High dose steroids - methylprednisolone 5 days

22
Q

MS treatment - reducing relapse rate

A

Beta-interferon

23
Q

MS treatment - fatigue

A

Amantadine

24
Q

MS treatment - spasticity

A

Baclofen/gabapentin/diazepam

25
Q

MS treatment - oscillopsia

A

Gabapentin

26
Q

L3 nerve root compression

A

-Sensory loss over anterior thigh
-Weak quadriceps
-Reduced knee reflex
-Positive femoral stretch test

27
Q

L4 nerve root compression

A

-Sensory loss anterior knee
-Weak quadriceps
-Reduced knee reflex
-Positive femoral stretch test

28
Q

L5 nerve root compression

A

-Sensory loss dorsum of foot
-Weakness in foot and big toe dorsiflexion
-Reflexes intact
-Positive sciatic nerve stretch test

29
Q

S1 nerve root compression

A

-Sensory loss posterolateral leg and lateral foot
-Weakness in plantar flexion
-Reduced ankle reflex
-Positive sciatic nerve stretch test

30
Q

Drugs used in mild to moderate Alzheimer’s: 1st line

A

Acetylcholinesterase inhibitor: donepezil, galantamine or rivastigmine

31
Q

Drugs used in Alzheimer’s: 2nd line

A

Memantine (NMDA antagonist)